Cargando…
PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial
BACKGROUND: Infectious keratitis is a major cause of global blindness. We tested whether standalone photoactivated chromophore corneal cross-linking (PACK-CXL) may be an effective first-line treatment in early to moderate infectious keratitis, compared with standard antimicrobial treatment. METHODS:...
Autores principales: | Hafezi, Farhad, Hosny, Mohammed, Shetty, Rohit, Knyazer, Boris, Chen, Shihao, Wang, Qinmei, Hashemi, Hassan, Torres-Netto, Emilio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742313/ https://www.ncbi.nlm.nih.gov/pubmed/34996516 http://dx.doi.org/10.1186/s40662-021-00272-0 |
Ejemplares similares
-
PACK-CXL: Corneal cross-linking in infectious keratitis
por: Tabibian, David, et al.
Publicado: (2016) -
PACK-CXL: Corneal Cross-linking for Treatment of Infectious Keratitis
por: Tabibian, David, et al.
Publicado: (2015) -
Commentary: PACK-CXL in fungal keratitis
por: Deshmukh, Rashmi
Publicado: (2019) -
Accelerated high fluence photoactivated chromophore for infectious keratitis—corneal cross-linking (PACK-CXL) at the slit lamp: a pilot study
por: Olshaker, Hagar, et al.
Publicado: (2023) -
Medical Management versus PACK-CXL in Dogs with Infectious Keratitis: A Randomized Controlled Trial Protocol
por: Kowalska, Malwina E., et al.
Publicado: (2022)